Sunshine Biopharma Inc (SBFM)

[hssbwwmp]

Did you know: In August 2021, Nora Pharma, a Canadian pharmaceutical company, entered into an exclusive agreement with a biopharmaceutical partner to acquire the commercial rights to a biosimilar drug. ”This announcement marks the culmination of a major shift for our business. Over the past 12 months, we have made a significant change in our activities, moving from the private generic sector exclusively in Quebec to a national company with a drug portfolio that will double in size over the next three years. Our announcement today will also support the objective of both private insurers and public formularies to reduce the costs of acquiring biosimilars. It also sends a powerful signal of our ambition to become a key player in the Canadian pharmaceutical landscape. Finally, the addition of a biosimilar drug to our portfolio will create new job opportunities within the organization, in addition to accelerating the growth and competitiveness of the company. ” – Malek Chamoun, president

It appears the Biosimilar drug market is expanding. Saw this today about Biogen:

14:34 ET -- Biogen Inc. is one of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The company said the U.S. Food and Drug Administration has accepted for review the abbreviated Biologics License Application for BIIB800, a proposed biosimilar to Roche Holdings AG anti-inflammatory drug Actemra. In September, the European Medicines Agency accepted a BIIB800 Marketing Authorization Application for review. Biogen previously reported data from a Phase 3 trial demonstrating equivalent efficacy and comparable safety and immunogenicity profile.

More here about the FDA and Biosimilars: https://www.fda.gov/drugs/therapeutic-biologics-applications-bla/biosimilars